Theradiag SA Cash Flow Conversion Efficiency

Latest as of June 2025: 1.404x

Theradiag SA cash flow conversion efficiency. Based on the latest financial reports, Theradiag SA (ALTHE) has a cash flow conversion efficiency ratio of 1.404x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.56 Million ≈ $-4.17 Million USD) by net assets (€-2.54 Million ≈ $-2.97 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Theradiag SA (2011–2024)

Cash flow conversion efficiency of Theradiag SA from 2011 to 2024. This chart illustrates how Theradiag SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Theradiag SA share price for real-time trading data and today's change.

Theradiag SA Cash Flow Conversion Ratio Explained

Theradiag SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Theradiag SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theradiag SA ranked by their cash flow conversion efficiency. Also see ALTHE market cap for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
HBR Realty Empreendimentos Imobiliários S.A SA:HBRE3	0.143x
Cyclone Metals Ltd AU:CLE	-0.088x
PBT Holdings Limited JSE:PBT	0.319x
Cellid Co. Ltd KQ:299660	-0.031x
Atakule Gayrimenkul Yatirim Ortakligi AS IS:AGYO	0.006x
Singbao International Co Ltd TWO:6130	-0.027x
Oricom Inc KQ:010470	0.142x
Acorn Energy, Inc. NASDAQ:ACFN	0.025x

Annual Cash Flow Conversion Efficiency for Theradiag SA (2011–2024)

The table below shows the annual cash flow conversion efficiency of Theradiag SA from 2011 to 2024. Review financial agility of Theradiag SA to assess the company's free cash flow relative to its total liabilities.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-114.00 ≈ $-133.28	€-2.91 Million ≈ $-3.40 Million	25535.088x	+5810417.91%
2023-12-31	€5.65 Million ≈ $6.61 Million	€-2.48 Million ≈ $-2.90 Million	-0.439x	+95.45%
2022-12-31	€544.87K ≈ $637.01K	€-5.27 Million ≈ $-6.16 Million	-9.665x	-416.71%
2021-12-31	€-1.27 Million ≈ $-1.49 Million	€-3.88 Million ≈ $-4.54 Million	3.052x	+197.46%
2020-12-31	€-3.24 Million ≈ $-3.79 Million	€-3.32 Million ≈ $-3.88 Million	1.026x	-97.79%
2019-12-31	€-79.73K ≈ $-93.21K	€-3.69 Million ≈ $-4.32 Million	46.321x	+420.83%
2018-12-31	€-531.93K ≈ $-621.88K	€-4.73 Million ≈ $-5.53 Million	8.894x	+554.82%
2017-12-31	€3.47 Million ≈ $4.06 Million	€-6.79 Million ≈ $-7.93 Million	-1.955x	-37.04%
2016-12-31	€5.58 Million ≈ $6.53 Million	€-7.97 Million ≈ $-9.31 Million	-1.427x	+78.31%
2015-12-31	€756.80K ≈ $884.78K	€-4.98 Million ≈ $-5.82 Million	-6.579x	-252.44%
2014-12-31	€2.77 Million ≈ $3.24 Million	€-5.18 Million ≈ $-6.05 Million	-1.867x	-275.77%
2013-12-31	€-3.80 Million ≈ $-4.45 Million	€-4.04 Million ≈ $-4.72 Million	1.062x	+111.88%
2012-12-31	€297.60K ≈ $347.92K	€-2.66 Million ≈ $-3.11 Million	-8.938x	-13.01%
2011-12-31	€120.37K ≈ $140.73K	€-952.02K ≈ $-1.11 Million	-7.909x	--

About Theradiag SA

PA:ALTHE France Medical Devices

Market Cap

$48.42 Million

€41.42 Million EUR

Market Cap Rank

#22772 Global

#356 in France

Share Price

€0.70

Change (1 day)

-2.50%

52-Week Range

€0.43 - €0.87

All Time High

€8.20